About CERUS CORPORATION
Cerus Corporation is dedicated to safeguarding the world's blood supply and aims to become the preeminent global blood products company. Based in Concord, California, the company develops and supplies technologies and pathogen-protected blood components to blood centers, hospitals, and patients.
Development and supply of vital technologies and pathogen-protected blood componentsINTERCEPT Blood System for platelets and plasma with both CE mark and FDA approvalProduction of Pathogen Reduced Cryoprecipitated Fibrinogen Complex (INTERCEPT Fibrinogen Complex)Late-stage clinical development of the INTERCEPT red blood cell system
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| THE INTERCEPT BLOOD SYSTEM FOR PLATELETS IS USED TO INACTIVATE A BROAD SPECTRUM OF VIRUSES, BACTERIA, PROTOZOA | Department of Defense | $87K | |
| SERVICE MAINTENANCE (2)CERUS INTERCEPT PLATELET FOR BASE YEAR PLUS FOUR (4) OPTION YEARS. | Department of Defense | $66K | |
| ANNUAL PREVENTATIVE MAINTENANCE OF INTERCEPT ILLUMINATORS - BASE AND 4 OPTION YEARS | Department of Defense | $66K | |
| (R) CERUS CORPORATION:1188061 [26-000202] | Department of Health and Human Services | $225K | |
| Federal contract award | Department of Defense | $59K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to CERUS CORPORATION right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.